Recurrent AL Amyloidosis
1 clinical trials · Condition
◉ Watch Recurrent AL Amyloidosis
| Record | Firm | Date |
|---|---|---|
| Venetoclax, MLN9708 (Ixazomib Citrate) and Dexamethasone for the Treatment of Relapsed or Refractory Light Chain Amyloidosis (NCT04847453) | National Cancer Institute (NCI) | 2022-08-03 |
Track Recurrent AL Amyloidosis automatically
Every clearance here is in the API, with alerts when new ones post.